Treatment (tx) patterns and clinical outcomes for patients (pts) with de novo versus recurrent HER2+ metastatic breast cancer (MBC).
Adam Brufsky
Consultant or Advisory Role - Genentech
Denise Aysel Yardley
Consultant or Advisory Role - Genentech
Peter Andrew Kaufman
Consultant or Advisory Role - Genentech
Honoraria - Genentech
Research Funding - Genentech
Marianne Ulcickas Yood
Consultant or Advisory Role - Genentech
Hope S. Rugo
Research Funding - Genentech/Roche
Musa Mayer
Consultant or Advisory Role - Genentech (U)
Cheng Seok Quah
Employment or Leadership Position - Genentech
Bongin Yoo
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Debu Tripathy
Consultant or Advisory Role - Genentech/Roche